The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients.
Saved in:
| Title: | The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients. |
|---|---|
| Authors: | Ghesquières H; Department of Hematology, Hopital Lyon Sud, Claude Bernard Lyon 1 University, Pierre Benite, France., Krzisch D; Department of Hematology, Assistance Publique Hopitaux de Paris, Hopital Saint Louis, Paris, France., Nicolas-Virelizier E; Department of Hematology, Centre Leon Berard, Claude Bernard Lyon 1 University, Lyon, France., Kanoun S; Department of Hematology, Cancer Research Center of Toulouse, Team 9, INSERM Unité Mixte de Recherche 1037, Toulouse, France., Gac AC; Department of Hematology, Institut d'Hematologie de Basse Normandie, Caen, France., Guidez S; Hematology Department, Centre Hospitalier Universitaire, Poitiers, France., Touati M; Department of Hematology, Hôpital Dupuytren, Centre Hospitalier Universitaire, Limoges, France., Laribi K; Hematology Department, Centre Hospitalier, Le Mans, France., Morschhauser F; Department of Hematology, Centre Hospitalier Universitaire Lille, Universite de Lille, ULR 7365 Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France., Bonnet C; Department of Hematology, University Hospital Liege, Liege, Belgium., Waultier-Rascalou A; Hematology of Department, Centre Hospitalier Universitaire, Nimes, France., Orsini-Piocelle F; Department of Hematology, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, France., André M; Department of Hematology, Centre Hospitalier Universitaire, Université Catholique de Louvain Namur, Université Catholique de Louvain, Yvoir, Belgium., Fournier M; Department of Statistics, Lymphoma Study Association Clinical Research, Hopital Lyon Sud, Pierre Benite, France., Morand F; Department of Statistics, Lymphoma Study Association Clinical Research, Hopital Lyon Sud, Pierre Benite, France., Berriolo-Riedinger A; Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France., Burroni B; Department of Pathology, Université de Paris Cité, Centre de Recherche des Cordeliers UMRS U1138 et GH Paris Centre APHP, Paris, France., Damotte D; Department of Pathology, Université de Paris Cité, Centre de Recherche des Cordeliers UMRS U1138 et GH Paris Centre APHP, Paris, France., Traverse-Glehen A; Department of Pathology, Hopital Lyon Sud, Claude Bernard Lyon 1 University, Pierre Benite, France., Quittet P; Department of Hematology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France., Casasnovas O; Department of Hematology, University Hospital F. Mitterrand and INSERM Unité Mixte de Recherche 1231, Dijon, France. |
| Source: | Blood [Blood] 2024 Mar 14; Vol. 143 (11), pp. 983-995. |
| Publication Type: | Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
